US Patent 12064445 Cytarabine conjugates for cancer therapy
Patent 12064445 was granted and assigned to Biosight Ltd. on August, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+16 properties)
Article (+276 characters)
US Patent 12064445 Cytarabine conjugates for cancer therapy
Article
Patent abstract
The present invention relates to conjugates comprising cytarabine and an amino acid for use in the treatment of cancer. In particular, the present invention relates to conjugates of cytarabine and aspartic acid for use in the treatment of hematological cancers.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Ruth Ben Yakar0
Stela Gengrinovitch0
Date of Patent
August 20, 2024
0Patent Application Number
173727400
Date Filed
July 12, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12064445 Cytarabine conjugates for cancer therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
